Paracetamol/Ibuprofen Jed (Ibuprofen, Paracetamol)

Paracetamol/Ibuprofen Jed combines two well‑known analgesic agents that act on the prostaglandin pathway to relieve discomfort and reduce fever.

• Headache: provides rapid relief of mild to moderate headache pain.
• Musculoskeletal pain: eases muscle, joint and back pain associated with strain or arthritis.
• Fever: lowers elevated body temperature in acute febrile illnesses.

• Paracetamol/Ibuprofen Jed works through dual mechanisms: paracetamol inhibits central cyclooxygenase enzymes, reducing prostaglandin synthesis in the brain to lower pain perception and temperature. Ibuprofen blocks peripheral cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, decreasing prostaglandin production at sites of inflammation, which adds anti‑inflammatory and analgesic effects.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Nausea: mild stomach upset that often resolves without intervention.
• Dyspepsia: discomfort or burning sensation in the upper abdomen.
• Headache: occasional worsening of headache despite treatment.
• Dizziness: transient light‑headedness, especially on standing.
• Rash: mild skin redness or itching.
• Elevated liver enzymes: mild, reversible changes in blood tests.

Serious or Rare Side Effects

• Gastrointestinal bleeding: black or tarry stools, vomiting blood, or severe abdominal pain.
• Hepatotoxicity: significant liver injury presenting with jaundice, dark urine, or fatigue.
• Renal impairment: reduced urine output, swelling, or sudden weight gain.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Anaphylaxis: rapid onset of breathing difficulty, swelling of the face or throat, and hypotension.
• Thrombotic events: increased risk of heart attack or stroke, especially with high‑dose ibuprofen.

When using Paracetamol/Ibuprofen Jed, consider the following safety measures:

• Assess liver function: review patients with existing liver disease.
• Evaluate renal function: caution in individuals with chronic kidney disease.
• Monitor cardiovascular risk: avoid high‑dose or prolonged ibuprofen use in at‑risk patients.
• Avoid concurrent NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs.
• Limit alcohol intake: excessive alcohol can increase hepatotoxic risk.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Paracetamol/Ibuprofen Jed can interact with several medicines; clinicians should review patient medication lists.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
• Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.
• Lithium: ibuprofen may raise lithium serum levels, risking toxicity.
• Methotrexate: ibuprofen can reduce renal clearance, raising methotrexate toxicity.
• ACE inhibitors/ARBs: may diminish renal protective effects and increase kidney injury risk.

Moderate Interactions (Monitor Closely)

• Diuretics: potential for reduced diuretic efficacy and electrolyte imbalance.
• Corticosteroids: additive risk of gastrointestinal ulceration.
• Antihypertensives: ibuprofen may blunt blood‑pressure‑lowering effects.
• Anticonvulsants (e.g., carbamazepine): may alter paracetamol metabolism.
• Oral hypoglycemics: ibuprofen can affect glucose control in some patients.